Bert B.
- Country
- The Netherlands
- Department
- Surgery
Research Overview
- Phase II/III Randomized Trial of Autologous Dendritic Cell Vaccine (MesoPher) Following FOLFIRINOX in Patients with Borderline Resectable Pancreatic Cancer
- Comparison of Perioperative and Adjuvant mFOLFIRINOX Regimens in Patients with Resectable Non-Metastatic Pancreatic Cancer
- Evaluation of Perioperative mFOLFIRINOX and Surgical Resection Versus mFOLFIRINOX Monotherapy in Oligometastatic Pancreatic Cancer: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 16 of 56 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating complex gastrointestinal cancers, with particular focus on pancreatic cancer and colorectal liver metastases. Their expertise extends to both resectable and borderline resectable cases.
- Pancreatic Cancer Treatment Approaches
- Colorectal Liver Metastases Management
- Esophageal Adenocarcinoma
Urological Oncology
The investigator demonstrates significant expertise in treating urological malignancies, particularly focusing on metastatic renal cell carcinoma and muscle invasive bladder cancer. Their work includes bladder-sparing therapeutic approaches.
- Renal Cell Carcinoma Treatments
- Bladder Cancer Management
- Organ Preservation Strategies
Advanced Therapeutic Applications
The investigator works with innovative treatment approaches including immunotherapy combinations and targeted therapies for various conditions, from inflammatory bowel disease to solid tumors.
- Immune Checkpoint Inhibitor Therapy
- Targeted Molecular Treatments
- Cardiovascular Critical Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.